
zzso contrast agents with zzso into zzso followed by variable zzso zzso represent a unique class of zzso MR contrast zzso Two zzso contrast agents, zzso zzso and zzso zzso are already clinically zzso A third zzso contrast agent, zzso is under zzso The purpose of this review is to provide an overview on the properties, clinical development and application of these three zzso contrast zzso zzso zzso zzso zzso contrast agents combine established features of zzso agents with the advantages of zzso zzso The detection and zzso of focal liver disease appears to be improved compared to zzso zzso zzso with unspecific contrast agents and zzso zzso To decrease the total time spent by a patient in the MR zzso it is zzso to administer the agent immediately after acquisition of zzso zzso zzso After infusion or zzso injection (with dynamic zzso zzso or zzso zzso of the contrast agent, moderately and heavily zzso images are zzso zzso zzso zzso is started upon completion of zzso zzso for zzso zzso and zzso as early as 20 zzso following injection, while zzso zzso scans are obtained zzso zzso following zzso zzso acquisition techniques with near zzso zzso pulse sequences with fat zzso parallel the technical progress made by zzso combined with an unparalleled improvement in zzso zzso The individual decision that zzso contrast agent one uses is partly based on personal zzso No comparative studies have been conducted comparing the advantages or disadvantages of all three agents directly against each zzso 

